RapidAI

RapidAI is a healthcare technology company that specializes in AI-driven imaging solutions for cerebrovascular and neurovascular conditions, including stroke and trauma. Their platform analyzes brain scans, such as CT and MRI images, to assist physicians in diagnosing and treating conditions like stroke and subdural hematomas with speed and accuracy. The company offers advanced clinical decision support software that enhances image analysis beyond simple triage. It provides detailed visualization and quantification of disease states, enabling faster clinical decisions. RapidAI's tools integrate smoothly into hospital workflows through PACS systems and mobile applications, facilitating collaboration among stroke teams and radiologists. Their technology is clinically validated and FDA-cleared for various applications, including the detection of intracranial hemorrhages. RapidAI's solutions are used in over 1,600 hospitals across more than 60 countries, significantly improving patient outcomes and operational efficiency in large health systems.

• Employees 260
• Founded 2012
• Annual Revenue $25000000
• Total Funding $102300000